The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Expansion Is Expected For The Deoxycholic Acid Obesity Drugs Market Over The Forecast Period?
The deoxycholic acid obesity drugs market has experienced rapid expansion in its size over recent years. Forecasts indicate that the market will increase from $0.5 billion in 2025 to $0.57 billion in 2026, with a compound annual growth rate (CAGR) of 14.4%. This historic growth is largely due to escalating consumer knowledge of aesthetic procedures, the widening reach of medical aesthetics clinics, a greater preference for minimally invasive techniques, the widespread availability of approved deoxycholic acid formulations, and an uptick in disposable income.
The deoxycholic acid obesity drugs market size is predicted to undergo significant expansion in the coming years. It is forecast to reach $0.97 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 14.1%. This projected growth is driven by an increasing demand for personalized aesthetic treatments, the expansion of combination aesthetic protocols, a rising focus on body contouring procedures, growing investments in aesthetic drug innovation, and increasing penetration in emerging markets. Key developments anticipated during this period include a greater adoption of non-surgical fat reduction procedures, rising demand for injectable aesthetic treatments, the evolving development of combination lipolytic therapies, the expansion of clinic-based body contouring services, and an enhanced focus on patient-specific aesthetic outcomes.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28192&type=smp
What Primary Factors Are Fueling The Expansion Of The Deoxycholic Acid Obesity Drugs Market?
An anticipated increase in obesity rates is projected to stimulate expansion within the deoxycholic acid obesity drug market. These rates indicate the proportion of a population considered overweight or obese based on their Body Mass Index (BMI). The uptick in obesity stems from unhealthy eating patterns, including significant consumption of processed items and sugary beverages, which leads to surplus calorie storage as body fat. Deoxycholic acid medications for obesity contribute to lowering these rates by dissolving and removing surplus fat cells, thereby facilitating localized fat reduction and enhancing body shape. For example, data released in May 2025 by the UK’s Office for Health Improvement and Disparities showed that between 2023 and 2024, approximately 64.5% of adults aged 18 and above in England were overweight or obese, an increase from 64.0% recorded between 2022 and 2023. Consequently, the expanding prevalence of obesity is a key factor boosting the deoxycholic acid obesity drug market’s expansion.
How Is The Deoxycholic Acid Obesity Drugs Market Examined Through Segment Analysis?
The deoxycholic acid obesity drugs market covered in this report is segmented –
1) By Drug Type: ATX-101 (Deoxycholic Acid Injection Or Kybella Or Belkyra), Experimental Or Compounded Deoxycholic Acid Formulations, Combination Therapies, Oral Deoxycholic Acid Products
2) By Formulation: Injectable, Topical
3) By Distribution Channel: Direct Sales, Retail Pharmacies, Online Pharmacies
4) By Application: Submental Fat Reduction, Abdominal Fat Reduction, Thighs Arms And Flanks, Lipomas And Localized Fat, Cellulite Management
5) By End-User: Aesthetic Clinics, Dermatology Clinics, Plastic Surgery Centers, Hospitals, Home Administration
Subsegments:
1) By ATX-101 (Deoxycholic Acid Injection or Kybella or Belkyra): Standard Injectable, High-Purity Formulations, Combination Injection Therapies
2) By Experimental Or Compounded Deoxycholic Acid Formulation: Clinical Trial Formulations, Compounded Customized Formulations
3) By Combination Therapies: Deoxycholic Acid + Lipolytic Agents, Deoxycholic Acid + Enzyme Therapy
4) By Oral Deoxycholic Acid Products: Capsules, Tablets, Liquid Formulations
Which Trends Are Shaping The Deoxycholic Acid Obesity Drugs Market Landscape?
Major companies active in the deoxycholic acid obesity drug market are concentrating on creating advanced products, like injectable deoxycholic acid obesity drugs, to enhance the effectiveness of treatments and improve results for patients. Injectable deoxycholic acid obesity drugs employ deoxycholic acid, a substance that breaks down fat cells, and are administered as an injection to specifically target and reduce fat in particular areas. For instance, in March 2024, LG Chem Ltd., a South Korea-based chemicals company, unveiled Bellacholine for reducing submental fat. This nonsurgical injection is formulated to diminish moderate to severe submental fat (double chin) by safely destroying fat cells with deoxycholic acid. It provides benefits such as a body-compatible pH, minimal sedimentation, and the promotion of skin elasticity through collagen synthesis.
Who Are The Leading Firms Participating In The Deoxycholic Acid Obesity Drugs Market?
Major companies operating in the deoxycholic acid obesity drugs market are AbbVie Inc., Cipla Ltd., Glenmark Life Sciences Limited, Curia Global Inc., Daewoong Pharmaceutical Co. Ltd., Actylis, ICE Pharma, Cayman Chemical Company, Nacalai Tesque Inc., Sichuan Huiyu Pharmaceutical, Conscientia Industrial, Manus Aktteva Biopharma LLP, Jeevan Chemicals & Pharmaceuticals, Anhui Chem-Bright Bioengineering Co. Ltd., GlpBio Technology LLC, Legere Pharmaceuticals, Otto Chemie Pvt. Ltd., BOC Sciences, Guangzhou Green Cross Pharmaceutical, Prodotti Chimici e Alimentari S.P.A
Access The Complete Deoxycholic Acid Obesity Drugs Market Report:
Which Region Contributes The Most To The Deoxycholic Acid Obesity Drugs Market?
North America was the largest region in the deoxycholic acid obesity drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxycholic acid obesity drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Deoxycholic Acid Obesity Drugs Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=28192&type=smp
Browse Through More Reports Similar to the Global Deoxycholic Acid Obesity Drugs Market 2026, By The Business Research Company
Metabolic Disorders Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report
Weight Loss Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/weight-loss-drugs-global-market-report
Weight Loss Supplements Market Report 2026
https://www.thebusinessresearchcompany.com/report/weight-loss-supplements-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model